Citigroup Bets Big on Healthcare and Rails
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Citigroup's Daniel Grosslight lifted McKesson to Buy with a $1,000 price target. That is up sharply from $945. The drug distributor carries a $98 billion market cap. Grosslight also upgraded Cardinal Health to Buy, raising the target to $265 from $245.
On the rails, Citi's Ariel Rosa boosted targets across the board. Union Pacific got a Buy with a $349 target, up from $326. Norfolk Southern and CSX also saw target lifts, though both stay at Hold. The moves suggest Citi sees improving freight conditions ahead.
In tech, Dell Technologies analysts pushed consensus targets to $503 from $489. Hewlett Packard Enterprise targets nudged up to $64.34. Both names are riding AI infrastructure spending.
Analysts slashed targets across the utility sector. Duke Energy, Xcel Energy, FirstEnergy, Entergy, and Southern Company all saw downward target revisions. The cuts were small in dollar terms but reflect pressure from rising rates.
DexCom received a new analyst recommendation. The glucose monitoring firm has a consensus target of $86.12 and a $27.6 billion market cap.
Stocks in this article
How this article was generated
- Generated
- 26 Jul 2026, 16:20
- Prompt version
- v1.0
- Data sources
- Analyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.